|
1
|
Lomas A, Leonardi-Bee J and Bath-Hextall
F: A systematic review of worldwide incidence of nonmelanoma skin
cancer. Br J Dermatol. 166:1069–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holm AS, Nissen CV and Wulf HC: Basal cell
carcinoma is as common as the sum of all other cancers:
Implications for treatment capacity. Acta Derm Venereol.
96:505–509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Socialstyrelsen: Cancer i siffror.
2013.http://www.socialstyrelsen.se/publikationer2013/2013-6-5April
27–2015
|
|
4
|
Wong CS, Strange RC and Lear JT: Basal
cell carcinoma. BMJ. 327:794–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Housman TS, Feldman SR, Williford PM,
Fleischer AB Jr, Goldman ND, Acostamadiedo JM and Chen GJ: Skin
cancer is among the most costly of all cancers to treat for the
Medicare population. J Am Acad Dermatol. 48:425–429. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gordon LG and Rowell D: Health system
costs of skin cancer and cost-effectiveness of skin cancer
prevention and screening: A systematic review. Eur J Cancer Prev.
24:141–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sekulic A, Migden MR, Oro AE, Dirix L,
Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander
PA, et al: Efficacy and safety of vismodegib in advanced basal-cell
carcinoma. N Engl J Med. 366:2171–2179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bonilla X, Parmentier L, King B, Bezrukov
F, Kaya G, Zoete V, Seplyarskiy VB, Sharpe HJ, McKee T, Letourneau
A, et al: Genomic analysis identifies new drivers and progression
pathways in skin basal cell carcinoma. Nat Genet. 48:398–406. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moan J, Grigalavicius M, Baturaite Z,
Dahlback A and Juzeniene A: The relationship between UV exposure
and incidence of skin cancer. Photodermatol Photoimmunol Photomed.
31:26–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Birch-Machin MA and Swalwell H: How
mitochondria record the effects of UV exposure and oxidative stress
using human skin as a model tissue. Mutagenesis. 25:101–107. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu J, Sharma LK and Bai Y: Implications of
mitochondrial DNA mutations and mitochondrial dysfunction in
tumorigenesis. Cell Res. 19:802–815. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tina E, Lindqvist BM, Gabrielson M,
Lubovac Z, Wegman P and Wingren S: The mitochondrial transporter
SLC25A43 is frequently deleted and may influence cell proliferation
in HER2-positive breast tumors. BMC Cancer. 12:3502012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lindqvist BM, Farkas SA, Wingren S and
Nilsson TK: DNA methylation pattern of the SLC25A43 gene in breast
cancer. Epigenetics. 7:300–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haitina T, Lindblom J, Renström T and
Fredriksson R: Fourteen novel human members of mitochondrial solute
carrier family 25 (SLC25) widely expressed in the central nervous
system. Genomics. 88:779–790. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fiermonte G, Paradies E, Todisco S,
Marobbio CM and Palmieri F: A novel member of solute carrier family
25 (SLC25A42) is a transporter of coenzyme A and adenosine
3′,5′-diphosphate in human mitochondria. J Biol Chem.
284:18152–18159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gabrielson M, Reizer E, Stål O and Tina E:
Mitochondrial regulation of cell cycle progression through
SLC25A43. Biochem Biophys Res Commun. 469:1090–1096. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Detre S, Jotti G Saclani and Dowsett M: A
‘quickscore’ method for immunohistochemical semiquantitation:
Validation for oestrogen receptor in breast carcinomas. J Clin
Pathol. 48:876–878. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
The Human Protein Atlas: version 16.1.
http://www.proteinatlas.org/ENSG00000077713-SLC25A43/antibodyMarch
9–2017
|
|
21
|
Osellame LD, Blacker TS and Duchen MR:
Cellular and molecular mechanisms of mitochondrial function. Best
Pract Res Clin Endocrinol Metab. 26:711–723. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martinez-Reyes I and Cuezva JM: The
H(+)-ATP synthase: A gate to ROS-mediated cell death or cell
survival. Biochim Biophys Acta. 1837:1099–1112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakamaki T, Casimiro MC, Ju X, Quong AA,
Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, et al: Cyclin D1
determines mitochondrial function in vivo. Mol Cell Biol.
26:5449–5469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Van den Bogert C, Muus P, Haanen C,
Pennings A, Melis TE and Kroon AM: Mitochondrial biogenesis and
mitochondrial activity during the progression of the cell cycle of
human leukemic cells. Exp Cell Res. 178:143–153. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Howell BG, Solish N, Lu C, Watanabe H,
Mamelak AJ, Freed I, Wang B and Sauder DN: Microarray profiles of
human basal cell carcinoma: Insights into tumor growth and
behavior. J Dermatol Sci. 39:39–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The Human Protein Atlas: version 16.1.
http://www.proteinatlas.org/ENSG00000077713-SLC25A43/tissueMarch
9–2017
|
|
28
|
Asada M, Schaart FM, de Almeida HL Jr,
Korge B, Kurokawa I, Asada Y and Orfanos CE: Solid basal cell
epithelioma (BCE) possibly originates from the outer root sheath of
the hair follicle. Acta Derm Venereol. 73:286–292. 1993.PubMed/NCBI
|
